Provided by Tiger Fintech (Singapore) Pte. Ltd.

C4 Therapeutics, Inc.

1.40
+0.150012.00%
Post-market: 1.450.0500+3.57%18:20 EDT
Volume:1.50M
Turnover:2.10M
Market Cap:99.39M
PE:-0.92
High:1.49
Open:1.24
Low:1.20
Close:1.25
Loading ...
Oct 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 11, 2024

Major Issues Report

Form 8-K - Current report
Sep 03, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Jun 21, 2024

Major Issues Report

Form 8-K - Current report
Jun 10, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
Mar 08, 2024

Major Issues Report

Form 8-K - Current report
Mar 04, 2024

Major Issues Report

Form 8-K - Current report
Feb 22, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 22, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 22, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 05, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2024

Major Issues Report

Form 8-K - Current report